These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31951535)

  • 1. Therapeutic Targeting of mTORC2 in mTORopathies.
    Dentel B; Escamilla CO; Tsai PT
    Neuron; 2019 Dec; 104(6):1032-1033. PubMed ID: 31951535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma.
    Zhang X; Wang X; Xu T; Zhong S; Shen Z
    Tumour Biol; 2015 Jul; 36(7):5273-81. PubMed ID: 25666752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperactivity of mTORC1- and mTORC2-dependent signaling mediates epilepsy downstream of somatic PTEN loss.
    Cullen ER; Safari M; Mittelstadt I; Weston MC
    Elife; 2024 Mar; 12():. PubMed ID: 38446016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Approaches and Future Directions for the Treatment of mTORopathies.
    Karalis V; Bateup HS
    Dev Neurosci; 2021; 43(3-4):143-158. PubMed ID: 33910214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects.
    Jhanwar-Uniyal M; Amin AG; Cooper JB; Das K; Schmidt MH; Murali R
    Adv Biol Regul; 2017 May; 64():39-48. PubMed ID: 28189457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin.
    Zou Z; Chen J; Yang J; Bai X
    Curr Cancer Drug Targets; 2016; 16(4):288-304. PubMed ID: 26563881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP-site binding inhibitor effectively targets mTORC1 and mTORC2 complexes in glioblastoma.
    Neil J; Shannon C; Mohan A; Laurent D; Murali R; Jhanwar-Uniyal M
    Int J Oncol; 2016 Mar; 48(3):1045-52. PubMed ID: 26719046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTORC2, but not mTORC1, is required for hippocampal mGluR-LTD and associated behaviors.
    Zhu PJ; Chen CJ; Mays J; Stoica L; Costa-Mattioli M
    Nat Neurosci; 2018 Jun; 21(6):799-802. PubMed ID: 29786082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryo-EM structure of human mTOR complex 2.
    Chen X; Liu M; Tian Y; Li J; Qi Y; Zhao D; Wu Z; Huang M; Wong CCL; Wang HW; Wang J; Yang H; Xu Y
    Cell Res; 2018 May; 28(5):518-528. PubMed ID: 29567957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted inhibition of mTORC2 prevents osteosarcoma cell migration and promotes apoptosis.
    Wang X; Lai P; Zhang Z; Huang M; Wang L; Yin M; Jin D; Zhou R; Bai X
    Oncol Rep; 2014 Jul; 32(1):382-8. PubMed ID: 24840134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular regulation of apoptotic machinery and lipid metabolism by mTORC1/mTORC2 dual inhibitors in preclinical models of HER2+/PIK3CAmut breast cancer.
    Qian J; Chen Y; Meng T; Ma L; Meng L; Wang X; Yu T; Zask A; Shen J; Yu K
    Oncotarget; 2016 Oct; 7(41):67071-67086. PubMed ID: 27563814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
    Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
    PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of mTOR signaling affects cone function, cone structure and expression of cone specific proteins without affecting cone survival.
    Ma S; Venkatesh A; Langellotto F; Le YZ; Hall MN; Rüegg MA; Punzo C
    Exp Eye Res; 2015 Jun; 135():1-13. PubMed ID: 25887293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic target of rapamycin complex 1 and 2 in human temporal lobe epilepsy.
    Talos DM; Jacobs LM; Gourmaud S; Coto CA; Sun H; Lim KC; Lucas TH; Davis KA; Martinez-Lage M; Jensen FE
    Ann Neurol; 2018 Feb; 83(2):311-327. PubMed ID: 29331082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR complex-2 stimulates acetyl-CoA and de novo lipogenesis through ATP citrate lyase in HER2/PIK3CA-hyperactive breast cancer.
    Chen Y; Qian J; He Q; Zhao H; Toral-Barza L; Shi C; Zhang X; Wu J; Yu K
    Oncotarget; 2016 May; 7(18):25224-40. PubMed ID: 27015560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced menin expression impairs rapamycin effects as evidenced by an increase in mTORC2 signaling and cell migration.
    Razmara M; Monazzam A; Skogseid B
    Cell Commun Signal; 2018 Oct; 16(1):64. PubMed ID: 30285764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial Cell mTOR Complex-2 Regulates Sprouting Angiogenesis.
    Farhan MA; Carmine-Simmen K; Lewis JD; Moore RB; Murray AG
    PLoS One; 2015; 10(8):e0135245. PubMed ID: 26295809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes.
    Weinberg MA
    Anticancer Drugs; 2016 Jul; 27(6):475-87. PubMed ID: 26918392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTORC2 (Rictor) in Alzheimer's Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons.
    Lee HK; Kwon B; Lemere CA; de la Monte S; Itamura K; Ha AY; Querfurth HW
    J Alzheimers Dis; 2017; 56(3):1015-1036. PubMed ID: 28035937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTORC1 and mTORC2 Expression Levels in Oral Squamous Cell Carcinoma: An Immunohistochemical and Clinicopathological Study.
    Kawasaki G; Naruse T; Furukawa K; Umeda M
    Anticancer Res; 2018 Mar; 38(3):1623-1628. PubMed ID: 29491094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.